Old Web
English
Sign In
Acemap
>
Paper
>
CTNI-76. PHASE 2 CLINICAL TRIAL OF VAL-083 IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM
CTNI-76. PHASE 2 CLINICAL TRIAL OF VAL-083 IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM
2020
Zhongping Chen
Chengcheng Guo
Qun Ying Yang
Shao Xiong Wu
Jia-wei Li
Jeffrey A Bacha
Greg Johnson
John Langlands
Richard Schwartz
Claire Kwan
Sarath Kanekal
Anne Steino
Lorena López
Dennis Brown
Keywords:
Double-Stranded DNA Breaks
newly diagnosed
Glioblastoma
standard of care
Oncology
O-6-methylguanine-DNA methyltransferase
Internal medicine
Troponin I
Temozolomide
Phases of clinical research
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]